カテゴリー： LP Information, 世界, 部品/材料

世界のエルクサドリンAPI市場予測 2023年-2029年

◆英語タイトル：Global Eluxadoline API Market Growth 2023-2029
	◆商品コード：LP23JU2211 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：109 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥549,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥823,500	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,098,000	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のエルクサドリンAPI市場」は、過去の販売実績から2022年の世界のエルクサドリンAPIの総販売量を検討し、2023年から2029年の予測されるエルクサドリンAPIの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のエルクサドリンAPIの市場規模を掲載し、XXX百万米ドル規模の世界のエルクサドリンAPI市場の詳細な分析を提供します。本インサイトレポートは、世界のエルクサドリンAPI業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のエルクサドリンAPI市場における各社の独自のポジションをより深く理解するために、エルクサドリンAPI製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のエルクサドリンAPI市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。エルクサドリンAPIの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。エルクサドリンAPIの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。エルクサドリンAPIのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

エルクサドリンAPIの世界主要メーカーとしては、Tecoland、 FCDA、 Teva Pharmaceutical Industries、 Pharmaffiliates、 Clearsynth、 Jigs chemical、 Shijiazhuang Dingmin Pharmaceutical Sciences、 CoreSyn、 Sjar-tech、 Widely、 Sichuan CheCo Pharmaceutical Technologyなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のエルクサドリンAPI市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではエルクサドリンAPI市場をセグメンテーションし、種類別 (純度98%以下、純度98%～99%、純度99%以上)、用途別 (研究、製薬)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：純度98%以下、純度98%～99%、純度99%以上

・用途別区分：研究、製薬

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のエルクサドリンAPI市場の10年間の市場状況・展望は？
・世界および地域別に見たエルクサドリンAPI市場成長の要因は何か？
・エルクサドリンAPIの市場機会はエンドマーケットの規模によってどのように変化するのか？
・エルクサドリンAPIのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：エルクサドリンAPIの年間販売量2018-2029、地域別現状・将来分析
・エルクサドリンAPIの種類別セグメント：純度98%以下、純度98%～99%、純度99%以上
・エルクサドリンAPIの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・エルクサドリンAPIの用途別セグメント：研究、製薬
・エルクサドリンAPIの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のエルクサドリンAPI市場
・企業別のグローバルエルクサドリンAPI市場データ：2018-2023年の年間販売量、市場シェア
・企業別のエルクサドリンAPIの年間売上：2018-2023年の売上、市場シェア
・企業別のエルクサドリンAPI販売価格
・主要企業のエルクサドリンAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

エルクサドリンAPIの地域別レビュー
・地域別のエルクサドリンAPI市場規模2018-2023：年間販売量、売上
・主要国別のエルクサドリンAPI市場規模2018-2023：年間販売量、売上
・南北アメリカのエルクサドリンAPI販売の成長
・アジア太平洋のエルクサドリンAPI販売の成長
・ヨーロッパのエルクサドリンAPI販売の成長
・中東・アフリカのエルクサドリンAPI販売の成長

南北アメリカ市場
・南北アメリカの国別のエルクサドリンAPI販売量、売上（2018-2023）
・南北アメリカのエルクサドリンAPIの種類別販売量
・南北アメリカのエルクサドリンAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のエルクサドリンAPI販売量、売上（2018-2023）
・アジア太平洋のエルクサドリンAPIの種類別販売量
・アジア太平洋のエルクサドリンAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のエルクサドリンAPI販売量、売上（2018-2023）
・ヨーロッパのエルクサドリンAPIの種類別販売量
・ヨーロッパのエルクサドリンAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のエルクサドリンAPI販売量、売上（2018-2023）
・中東・アフリカのエルクサドリンAPIの種類別販売量
・中東・アフリカのエルクサドリンAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・エルクサドリンAPIの製造コスト構造分析
・エルクサドリンAPIの製造プロセス分析
・エルクサドリンAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・エルクサドリンAPIの主要なグローバル販売業者
・エルクサドリンAPIの主要なグローバル顧客

地域別のエルクサドリンAPI市場予測レビュー
・地域別のエルクサドリンAPI市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・エルクサドリンAPIの種類別市場規模予測
・エルクサドリンAPIの用途別市場規模予測

主要企業分析
Tecoland、 FCDA、 Teva Pharmaceutical Industries、 Pharmaffiliates、 Clearsynth、 Jigs chemical、 Shijiazhuang Dingmin Pharmaceutical Sciences、 CoreSyn、 Sjar-tech、 Widely、 Sichuan CheCo Pharmaceutical Technology
・企業情報
・エルクサドリンAPI製品
・エルクサドリンAPI販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Eluxadoline is a medication taken by mouth for the treatment of diarrhea and abdominal pain in individuals with diarrhea-predominant irritable bowel syndrome (IBS-D).
LPI (LP Information)’ newest research report, the “Eluxadoline API Industry Forecast” looks at past sales and reviews total world Eluxadoline API sales in 2022, providing a comprehensive analysis by region and market sector of projected Eluxadoline API sales for 2023 through 2029. With Eluxadoline API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eluxadoline API industry.
This Insight Report provides a comprehensive analysis of the global Eluxadoline API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eluxadoline API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eluxadoline API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eluxadoline API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eluxadoline API.
The global Eluxadoline API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Eluxadoline API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Eluxadoline API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Eluxadoline API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Eluxadoline API players cover Tecoland, FCDA, Teva Pharmaceutical Industries, Pharmaffiliates, Clearsynth, Jigs chemical, Shijiazhuang Dingmin Pharmaceutical Sciences, CoreSyn and Sjar-tech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Eluxadoline API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Pharmaceutical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Tecoland
FCDA
Teva Pharmaceutical Industries
Pharmaffiliates
Clearsynth
Jigs chemical
Shijiazhuang Dingmin Pharmaceutical Sciences
CoreSyn
Sjar-tech
Widely
Sichuan CheCo Pharmaceutical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Eluxadoline API market?
What factors are driving Eluxadoline API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eluxadoline API market opportunities vary by end market size?
How does Eluxadoline API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eluxadoline API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Eluxadoline API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Eluxadoline API by Country/Region, 2018, 2022 & 2029
2.2 Eluxadoline API Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Eluxadoline API Sales by Type
2.3.1 Global Eluxadoline API Sales Market Share by Type (2018-2023)
2.3.2 Global Eluxadoline API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Eluxadoline API Sale Price by Type (2018-2023)
2.4 Eluxadoline API Segment by Application
2.4.1 Research
2.4.2 Pharmaceutical
2.5 Eluxadoline API Sales by Application
2.5.1 Global Eluxadoline API Sale Market Share by Application (2018-2023)
2.5.2 Global Eluxadoline API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Eluxadoline API Sale Price by Application (2018-2023)
3 Global Eluxadoline API by Company
3.1 Global Eluxadoline API Breakdown Data by Company
3.1.1 Global Eluxadoline API Annual Sales by Company (2018-2023)
3.1.2 Global Eluxadoline API Sales Market Share by Company (2018-2023)
3.2 Global Eluxadoline API Annual Revenue by Company (2018-2023)
3.2.1 Global Eluxadoline API Revenue by Company (2018-2023)
3.2.2 Global Eluxadoline API Revenue Market Share by Company (2018-2023)
3.3 Global Eluxadoline API Sale Price by Company
3.4 Key Manufacturers Eluxadoline API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eluxadoline API Product Location Distribution
3.4.2 Players Eluxadoline API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Eluxadoline API by Geographic Region
4.1 World Historic Eluxadoline API Market Size by Geographic Region (2018-2023)
4.1.1 Global Eluxadoline API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Eluxadoline API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Eluxadoline API Market Size by Country/Region (2018-2023)
4.2.1 Global Eluxadoline API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Eluxadoline API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Eluxadoline API Sales Growth
4.4 APAC Eluxadoline API Sales Growth
4.5 Europe Eluxadoline API Sales Growth
4.6 Middle East & Africa Eluxadoline API Sales Growth
5 Americas
5.1 Americas Eluxadoline API Sales by Country
5.1.1 Americas Eluxadoline API Sales by Country (2018-2023)
5.1.2 Americas Eluxadoline API Revenue by Country (2018-2023)
5.2 Americas Eluxadoline API Sales by Type
5.3 Americas Eluxadoline API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eluxadoline API Sales by Region
6.1.1 APAC Eluxadoline API Sales by Region (2018-2023)
6.1.2 APAC Eluxadoline API Revenue by Region (2018-2023)
6.2 APAC Eluxadoline API Sales by Type
6.3 APAC Eluxadoline API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eluxadoline API by Country
7.1.1 Europe Eluxadoline API Sales by Country (2018-2023)
7.1.2 Europe Eluxadoline API Revenue by Country (2018-2023)
7.2 Europe Eluxadoline API Sales by Type
7.3 Europe Eluxadoline API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eluxadoline API by Country
8.1.1 Middle East & Africa Eluxadoline API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Eluxadoline API Revenue by Country (2018-2023)
8.2 Middle East & Africa Eluxadoline API Sales by Type
8.3 Middle East & Africa Eluxadoline API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eluxadoline API
10.3 Manufacturing Process Analysis of Eluxadoline API
10.4 Industry Chain Structure of Eluxadoline API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eluxadoline API Distributors
11.3 Eluxadoline API Customer
12 World Forecast Review for Eluxadoline API by Geographic Region
12.1 Global Eluxadoline API Market Size Forecast by Region
12.1.1 Global Eluxadoline API Forecast by Region (2024-2029)
12.1.2 Global Eluxadoline API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eluxadoline API Forecast by Type
12.7 Global Eluxadoline API Forecast by Application
13 Key Players Analysis
13.1 Tecoland
13.1.1 Tecoland Company Information
13.1.2 Tecoland Eluxadoline API Product Portfolios and Specifications
13.1.3 Tecoland Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Tecoland Main Business Overview
13.1.5 Tecoland Latest Developments
13.2 FCDA
13.2.1 FCDA Company Information
13.2.2 FCDA Eluxadoline API Product Portfolios and Specifications
13.2.3 FCDA Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 FCDA Main Business Overview
13.2.5 FCDA Latest Developments
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Information
13.3.2 Teva Pharmaceutical Industries Eluxadoline API Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceutical Industries Main Business Overview
13.3.5 Teva Pharmaceutical Industries Latest Developments
13.4 Pharmaffiliates
13.4.1 Pharmaffiliates Company Information
13.4.2 Pharmaffiliates Eluxadoline API Product Portfolios and Specifications
13.4.3 Pharmaffiliates Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pharmaffiliates Main Business Overview
13.4.5 Pharmaffiliates Latest Developments
13.5 Clearsynth
13.5.1 Clearsynth Company Information
13.5.2 Clearsynth Eluxadoline API Product Portfolios and Specifications
13.5.3 Clearsynth Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Clearsynth Main Business Overview
13.5.5 Clearsynth Latest Developments
13.6 Jigs chemical
13.6.1 Jigs chemical Company Information
13.6.2 Jigs chemical Eluxadoline API Product Portfolios and Specifications
13.6.3 Jigs chemical Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jigs chemical Main Business Overview
13.6.5 Jigs chemical Latest Developments
13.7 Shijiazhuang Dingmin Pharmaceutical Sciences
13.7.1 Shijiazhuang Dingmin Pharmaceutical Sciences Company Information
13.7.2 Shijiazhuang Dingmin Pharmaceutical Sciences Eluxadoline API Product Portfolios and Specifications
13.7.3 Shijiazhuang Dingmin Pharmaceutical Sciences Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shijiazhuang Dingmin Pharmaceutical Sciences Main Business Overview
13.7.5 Shijiazhuang Dingmin Pharmaceutical Sciences Latest Developments
13.8 CoreSyn
13.8.1 CoreSyn Company Information
13.8.2 CoreSyn Eluxadoline API Product Portfolios and Specifications
13.8.3 CoreSyn Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 CoreSyn Main Business Overview
13.8.5 CoreSyn Latest Developments
13.9 Sjar-tech
13.9.1 Sjar-tech Company Information
13.9.2 Sjar-tech Eluxadoline API Product Portfolios and Specifications
13.9.3 Sjar-tech Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sjar-tech Main Business Overview
13.9.5 Sjar-tech Latest Developments
13.10 Widely
13.10.1 Widely Company Information
13.10.2 Widely Eluxadoline API Product Portfolios and Specifications
13.10.3 Widely Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Widely Main Business Overview
13.10.5 Widely Latest Developments
13.11 Sichuan CheCo Pharmaceutical Technology
13.11.1 Sichuan CheCo Pharmaceutical Technology Company Information
13.11.2 Sichuan CheCo Pharmaceutical Technology Eluxadoline API Product Portfolios and Specifications
13.11.3 Sichuan CheCo Pharmaceutical Technology Eluxadoline API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Sichuan CheCo Pharmaceutical Technology Main Business Overview
13.11.5 Sichuan CheCo Pharmaceutical Technology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Eluxadoline API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Eluxadoline API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Eluxadoline API Sales by Type (2018-2023) & (MT)
Table 7. Global Eluxadoline API Sales Market Share by Type (2018-2023)
Table 8. Global Eluxadoline API Revenue by Type (2018-2023) & ($ million)
Table 9. Global Eluxadoline API Revenue Market Share by Type (2018-2023)
Table 10. Global Eluxadoline API Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Eluxadoline API Sales by Application (2018-2023) & (MT)
Table 12. Global Eluxadoline API Sales Market Share by Application (2018-2023)
Table 13. Global Eluxadoline API Revenue by Application (2018-2023)
Table 14. Global Eluxadoline API Revenue Market Share by Application (2018-2023)
Table 15. Global Eluxadoline API Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Eluxadoline API Sales by Company (2018-2023) & (MT)
Table 17. Global Eluxadoline API Sales Market Share by Company (2018-2023)
Table 18. Global Eluxadoline API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Eluxadoline API Revenue Market Share by Company (2018-2023)
Table 20. Global Eluxadoline API Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Eluxadoline API Producing Area Distribution and Sales Area
Table 22. Players Eluxadoline API Products Offered
Table 23. Eluxadoline API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Eluxadoline API Sales by Geographic Region (2018-2023) & (MT)
Table 27. Global Eluxadoline API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Eluxadoline API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Eluxadoline API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Eluxadoline API Sales by Country/Region (2018-2023) & (MT)
Table 31. Global Eluxadoline API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Eluxadoline API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Eluxadoline API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Eluxadoline API Sales by Country (2018-2023) & (MT)
Table 35. Americas Eluxadoline API Sales Market Share by Country (2018-2023)
Table 36. Americas Eluxadoline API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Eluxadoline API Revenue Market Share by Country (2018-2023)
Table 38. Americas Eluxadoline API Sales by Type (2018-2023) & (MT)
Table 39. Americas Eluxadoline API Sales by Application (2018-2023) & (MT)
Table 40. APAC Eluxadoline API Sales by Region (2018-2023) & (MT)
Table 41. APAC Eluxadoline API Sales Market Share by Region (2018-2023)
Table 42. APAC Eluxadoline API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Eluxadoline API Revenue Market Share by Region (2018-2023)
Table 44. APAC Eluxadoline API Sales by Type (2018-2023) & (MT)
Table 45. APAC Eluxadoline API Sales by Application (2018-2023) & (MT)
Table 46. Europe Eluxadoline API Sales by Country (2018-2023) & (MT)
Table 47. Europe Eluxadoline API Sales Market Share by Country (2018-2023)
Table 48. Europe Eluxadoline API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Eluxadoline API Revenue Market Share by Country (2018-2023)
Table 50. Europe Eluxadoline API Sales by Type (2018-2023) & (MT)
Table 51. Europe Eluxadoline API Sales by Application (2018-2023) & (MT)
Table 52. Middle East & Africa Eluxadoline API Sales by Country (2018-2023) & (MT)
Table 53. Middle East & Africa Eluxadoline API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Eluxadoline API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Eluxadoline API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Eluxadoline API Sales by Type (2018-2023) & (MT)
Table 57. Middle East & Africa Eluxadoline API Sales by Application (2018-2023) & (MT)
Table 58. Key Market Drivers & Growth Opportunities of Eluxadoline API
Table 59. Key Market Challenges & Risks of Eluxadoline API
Table 60. Key Industry Trends of Eluxadoline API
Table 61. Eluxadoline API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Eluxadoline API Distributors List
Table 64. Eluxadoline API Customer List
Table 65. Global Eluxadoline API Sales Forecast by Region (2024-2029) & (MT)
Table 66. Global Eluxadoline API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Eluxadoline API Sales Forecast by Country (2024-2029) & (MT)
Table 68. Americas Eluxadoline API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Eluxadoline API Sales Forecast by Region (2024-2029) & (MT)
Table 70. APAC Eluxadoline API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Eluxadoline API Sales Forecast by Country (2024-2029) & (MT)
Table 72. Europe Eluxadoline API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Eluxadoline API Sales Forecast by Country (2024-2029) & (MT)
Table 74. Middle East & Africa Eluxadoline API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Eluxadoline API Sales Forecast by Type (2024-2029) & (MT)
Table 76. Global Eluxadoline API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Eluxadoline API Sales Forecast by Application (2024-2029) & (MT)
Table 78. Global Eluxadoline API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Tecoland Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 80. Tecoland Eluxadoline API Product Portfolios and Specifications
Table 81. Tecoland Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Tecoland Main Business
Table 83. Tecoland Latest Developments
Table 84. FCDA Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 85. FCDA Eluxadoline API Product Portfolios and Specifications
Table 86. FCDA Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. FCDA Main Business
Table 88. FCDA Latest Developments
Table 89. Teva Pharmaceutical Industries Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceutical Industries Eluxadoline API Product Portfolios and Specifications
Table 91. Teva Pharmaceutical Industries Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Teva Pharmaceutical Industries Main Business
Table 93. Teva Pharmaceutical Industries Latest Developments
Table 94. Pharmaffiliates Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 95. Pharmaffiliates Eluxadoline API Product Portfolios and Specifications
Table 96. Pharmaffiliates Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Pharmaffiliates Main Business
Table 98. Pharmaffiliates Latest Developments
Table 99. Clearsynth Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 100. Clearsynth Eluxadoline API Product Portfolios and Specifications
Table 101. Clearsynth Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Clearsynth Main Business
Table 103. Clearsynth Latest Developments
Table 104. Jigs chemical Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 105. Jigs chemical Eluxadoline API Product Portfolios and Specifications
Table 106. Jigs chemical Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Jigs chemical Main Business
Table 108. Jigs chemical Latest Developments
Table 109. Shijiazhuang Dingmin Pharmaceutical Sciences Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 110. Shijiazhuang Dingmin Pharmaceutical Sciences Eluxadoline API Product Portfolios and Specifications
Table 111. Shijiazhuang Dingmin Pharmaceutical Sciences Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. Shijiazhuang Dingmin Pharmaceutical Sciences Main Business
Table 113. Shijiazhuang Dingmin Pharmaceutical Sciences Latest Developments
Table 114. CoreSyn Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 115. CoreSyn Eluxadoline API Product Portfolios and Specifications
Table 116. CoreSyn Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. CoreSyn Main Business
Table 118. CoreSyn Latest Developments
Table 119. Sjar-tech Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 120. Sjar-tech Eluxadoline API Product Portfolios and Specifications
Table 121. Sjar-tech Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Sjar-tech Main Business
Table 123. Sjar-tech Latest Developments
Table 124. Widely Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 125. Widely Eluxadoline API Product Portfolios and Specifications
Table 126. Widely Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Widely Main Business
Table 128. Widely Latest Developments
Table 129. Sichuan CheCo Pharmaceutical Technology Basic Information, Eluxadoline API Manufacturing Base, Sales Area and Its Competitors
Table 130. Sichuan CheCo Pharmaceutical Technology Eluxadoline API Product Portfolios and Specifications
Table 131. Sichuan CheCo Pharmaceutical Technology Eluxadoline API Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Sichuan CheCo Pharmaceutical Technology Main Business
Table 133. Sichuan CheCo Pharmaceutical Technology Latest Developments
List of Figures
Figure 1. Picture of Eluxadoline API
Figure 2. Eluxadoline API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eluxadoline API Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Eluxadoline API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Eluxadoline API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Eluxadoline API Sales Market Share by Type in 2022
Figure 13. Global Eluxadoline API Revenue Market Share by Type (2018-2023)
Figure 14. Eluxadoline API Consumed in Research
Figure 15. Global Eluxadoline API Market: Research (2018-2023) & (MT)
Figure 16. Eluxadoline API Consumed in Pharmaceutical
Figure 17. Global Eluxadoline API Market: Pharmaceutical (2018-2023) & (MT)
Figure 18. Global Eluxadoline API Sales Market Share by Application (2022)
Figure 19. Global Eluxadoline API Revenue Market Share by Application in 2022
Figure 20. Eluxadoline API Sales Market by Company in 2022 (MT)
Figure 21. Global Eluxadoline API Sales Market Share by Company in 2022
Figure 22. Eluxadoline API Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Eluxadoline API Revenue Market Share by Company in 2022
Figure 24. Global Eluxadoline API Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Eluxadoline API Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Eluxadoline API Sales 2018-2023 (MT)
Figure 27. Americas Eluxadoline API Revenue 2018-2023 ($ Millions)
Figure 28. APAC Eluxadoline API Sales 2018-2023 (MT)
Figure 29. APAC Eluxadoline API Revenue 2018-2023 ($ Millions)
Figure 30. Europe Eluxadoline API Sales 2018-2023 (MT)
Figure 31. Europe Eluxadoline API Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Eluxadoline API Sales 2018-2023 (MT)
Figure 33. Middle East & Africa Eluxadoline API Revenue 2018-2023 ($ Millions)
Figure 34. Americas Eluxadoline API Sales Market Share by Country in 2022
Figure 35. Americas Eluxadoline API Revenue Market Share by Country in 2022
Figure 36. Americas Eluxadoline API Sales Market Share by Type (2018-2023)
Figure 37. Americas Eluxadoline API Sales Market Share by Application (2018-2023)
Figure 38. United States Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Eluxadoline API Sales Market Share by Region in 2022
Figure 43. APAC Eluxadoline API Revenue Market Share by Regions in 2022
Figure 44. APAC Eluxadoline API Sales Market Share by Type (2018-2023)
Figure 45. APAC Eluxadoline API Sales Market Share by Application (2018-2023)
Figure 46. China Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Eluxadoline API Sales Market Share by Country in 2022
Figure 54. Europe Eluxadoline API Revenue Market Share by Country in 2022
Figure 55. Europe Eluxadoline API Sales Market Share by Type (2018-2023)
Figure 56. Europe Eluxadoline API Sales Market Share by Application (2018-2023)
Figure 57. Germany Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Eluxadoline API Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Eluxadoline API Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Eluxadoline API Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Eluxadoline API Sales Market Share by Application (2018-2023)
Figure 66. Egypt Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Eluxadoline API Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Eluxadoline API in 2022
Figure 72. Manufacturing Process Analysis of Eluxadoline API
Figure 73. Industry Chain Structure of Eluxadoline API
Figure 74. Channels of Distribution
Figure 75. Global Eluxadoline API Sales Market Forecast by Region (2024-2029)
Figure 76. Global Eluxadoline API Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Eluxadoline API Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Eluxadoline API Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Eluxadoline API Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Eluxadoline API Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエルクサドリンAPI市場予測 2023年-2029年(Global Eluxadoline API Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のエルクサドリンAPI市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp